OraSure (NASDAQ: OSUR) CFO buys 22K shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
OraSure Technologies’ Chief Financial Officer Kenneth J. McGrath reported an open-market purchase of 22,021 shares of common stock. The shares were bought on March 13, 2026 at a weighted average price of $2.9985 per share, in multiple trades between $2.93 and $3.12. Following this transaction, he directly owns 557,262 shares. The purchase was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 28, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Buyer: 22,021 shares ($66,030)
Net Buy
1 txn
Insider
McGrath Kenneth J
Role
Chief Financial Officer
Bought
22,021 shs ($66K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 22,021 | $2.9985 | $66K |
Holdings After Transaction:
Common Stock — 557,262 shares (Direct)
Footnotes (1)
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2025. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.93 to $3.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
FAQ
What insider transaction did OraSure Technologies (OSUR) report for its CFO?
OraSure Technologies’ CFO Kenneth J. McGrath reported buying 22,021 shares of common stock. The open-market purchase occurred on March 13, 2026, and increased his direct holdings to 557,262 shares as disclosed in the Form 4 filing.
What type of transaction is reported in the OraSure (OSUR) Form 4 for the CFO?
The Form 4 reports an open-market purchase of common stock by the CFO. It is classified with transaction code "P," indicating a purchase in the open market or a private transaction rather than an option exercise or gift.
Did the OraSure (OSUR) Form 4 show any stock sales or derivative exercises by the CFO?
No stock sales or derivative exercises are reported in this Form 4. The summary shows one open-market purchase of 22,021 shares, with no sales or option exercises disclosed and no remaining derivative positions listed.